The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Japanese Clinical Practice Guideline for Diabetes 2016
Open accessAbstract
statements were developed separately as general questions and clinical questions based on published clinical evidence as well as expert consensus.This guideline offers key recommendations for clinical practice that are supported by scientific evidence from published studies.Studies of interest were obtained by a systematic search of the English and Japanese literature.The electronic databases used for literature search included at least MED-LINE and the Japanese ICHUSHI database (http://www.jamas. or.jp/).The search strategies used were developed by each author.The studies of interest were critically appraised by the authors to determine their relevance to the statements of the guideline and whether they were worth citing.Each study was assigned a level of evidence using the approach described in Table 1.Each statement for the CQs was assigned a grade of recommendation based on the total body of evidence as well as the risk-benefit balance, value, patient preferences, cost, and resources.Statements were graded as A (strongly recommended) or B (recommended), followed by the agreement rate among authors.Grade A or B by consensus reflects a recommendation based solely on the consensus of professionals and indicates that the recommendation was adopted with a ≥70% agreement rate among the authors.A summary table, including an identifier, the research design, the level of evidence and population, methods, and results of the cited articles was attached at the end of each chapter in the original Japanese version (The Japan Diabetes Society: Japanese Clinical Practice Guideline for diabetes 2016.Tokyo: Nankodo, 2016.).Scientific reports supporting a statement were cited as 'References' and additional guidelines or review articles were listed as 'Additional reference materials'.The guideline will be reviewed every 3 years, as there will be considerable advances in clinical research and practice that will require a re-evaluation of the scientific evidence as it becomes available.All potential conflicts of interest were disclosed by authors. GUIDELINE FOR THE DIAGNOSIS OF DIABETES MELLITUSQ1-1 How is diabetes diagnosed?(Figure 1)• The diagnosis of diabetes mellitus should be as comprehensive as possible.It is confirmed by the presence of chronic hyperglycemia, and by the presence of other factors, such as associated symptoms, clinical laboratory findings, a family history of diabetes, and the patient's body weight history 1-5 .For the diagnosis of diabetes, either of the following approaches is to be followed: ① Two assessments of the diabetic type in each patient (one blood glucose test is mandatory).② One assessment of the diabetic type (with mandatory blood glucose testing) along with the presence of chronic hyperglycemic symptoms*.(*typical symptoms of chronic hyperglycemia (e.g., dry mouth, polyposia, polyuria, body weight loss, or diabetic retinopathy).③ Evidence of a prior diagnosis of 'diabetes'.Q1-2 How is hyperglycemia assessed?(Figure 2)• Patients are to be classified into the normal type, borderline type, or diabetic type, based on the combination of fasting and 2-h post-75 g oral glucose tolerance test (OGTT) glucose values.• Patients whose fasting glucose values are 100-109 mg/dL (5.6-6.1 mmol/L) are classified into the 'high normal' category as part of the normal type 6 .• The OGTT is to be proactively considered in high-risk individuals (i.e., those who are suspected to have diabetes or the borderline type, those whose fasting glucose values are shown to be 'high-normal', those with HbA1c values of ≥5.6%, those with obesity or dyslipidemia, and those with a strong family history of diabetes 5 ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Research works printed but not linked: 232
- Kosaka K, 1982, Report of committee on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 25, 859
- World Health Organization, 1999, Report of a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus
- Kuzuya T, 1999, Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 42, 385
- 10.1007/s13340-010-0006-7 · DOI · Paper page
- Kadowaki T, 2008, Report of the Japan Diabetes Society's Committee on the diagnostic criteria for diabetes mellitus and glucose metabolism disorder―a new category of fasting plasma glucose values: “high‐normal”, J Jpn Diabetes Soc, 51, 281
- 10.1007/s13340-013-0122-2 · DOI · Paper page
- 10.1007/s13340-015-0210-6 · DOI
- 10.1111/jdi.12024 · DOI · Paper page
- 10.2169/naika.102.1829 · DOI
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Nakagawa Y, 2014, Impact of the duration of diabetes and frequency of counseling on the effectiveness of dietitian‐led medical nutrition therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 57, 813
- 10.1161/CIRCULATIONAHA.109.192521 · DOI · Paper page
- 10.1007/s00125-003-1160-2 · DOI · Paper page
- 10.1016/j.puhe.2007.02.014 · DOI · Paper page
- 10.1007/BF03262312 · DOI · Paper page
- 10.1371/journal.pone.0058861 · DOI · Paper page
- 10.2337/dc14-1140 · DOI · Paper page
- 10.1136/bmj.310.6972.83 · DOI · Paper page
- 10.1111/j.1600-051X.1988.tb01003.x · DOI · Paper page
- Bennett WL, 2011, AHRQ Comparative Effectiveness Reviews. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update
- Kaku K, 2006, Melbin observational research (MORE) study of metformin therapy in patients with type 2 diabetes mellitus, J Jpn Diabetes Soc, 49, 325
- 10.1001/archinte.168.8.820 · DOI · Paper page
- 10.1503/cmaj.080486 · DOI · Paper page
- 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
- 10.1007/s00125-012-2668-0 · DOI
- 10.1001/jama.299.13.1561 · DOI · Paper page
- 10.1007/s13340-011-0022-2 · DOI
- 10.1111/dom.12235 · DOI
- 10.1111/j.1463-1326.2007.00744.x · DOI · Paper page
- Iwakura T, 2010, A case of severe hypoglycemia induced by sitagliptin added to ongoing glimepiride therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 53, 505
- 10.1007/s13340-013-0109-z · DOI
- 10.1111/dom.12176 · DOI
- 10.1111/j.1463-1326.2009.01194.x · DOI
- 10.1111/j.1463-1326.2012.01618.x · DOI · Paper page
- 10.1111/dom.12244 · DOI · Paper page
- 10.7326/0003-4819-159-4-201308200-00007 · DOI · Paper page
- 10.1111/dom.12189 · DOI · Paper page
- 10.1046/j.1464-5491.2001.00582.x · DOI
- 10.2337/diacare.22.1.119 · DOI · Paper page
- 10.1046/j.1463-1326.2001.00141.x · DOI
- 10.1016/S0149-2918(00)83039-8 · DOI · Paper page
- 10.1111/j.1463-1326.2010.01326.x · DOI · Paper page
- 10.1185/03007990802711024 · DOI
- 10.1111/j.1464-5491.2009.02816.x · DOI
- 10.1111/dom.12229 · DOI
- 10.1111/ijcp.12322 · DOI · Paper page
- Takahashi Y, 1998, Clinical features of eighty‐six diabetic patients with post‐treatment painful neuropathy, J Jpn Diabetes Soc, 41, 165
- 10.7326/0003-4819-128-3-199802010-00001 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- Lawson ML, 1999, Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta‐analysis, Diabetes Care, 22, B35
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Shichiri M, 2000, Long‐term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21
- 10.1056/NEJMoa075392 · DOI · Paper page
- 10.1111/j.1463-1326.2008.00915.x · DOI
- 10.1016/S0168-8227(98)00003-5 · DOI
- 10.2337/diacare.25.2.330 · DOI · Paper page
- 10.1007/s00592-006-0231-5 · DOI
- 10.2337/diacare.24.10.1844 · DOI
- 10.2169/internalmedicine.46.0415 · DOI
- 10.7326/0003-4819-131-3-199908030-00004 · DOI · Paper page
- 10.1002/(SICI)1096-9136(1998120)15:12<997::AID-DIA716>3.0.CO;2-B · DOI
- 10.1016/S0149-2918(00)90005-5 · DOI
- Juntti‐Berggren L, 2000, Influence of acarbose on post‐prandial insulin requirements in patients with type 1 diabetes, Diabetes Nutr Metab, 13, 7
- Han A, 2004, Effect of combination therapy of premixtured 50 R and voglibose in patients with type 2 diabetes, J Jpn Diabetes Soc, 47, 137
- 10.1056/NEJM199803263381302 · DOI · Paper page
- 10.1016/j.clinthera.2005.05.005 · DOI
- 10.1016/j.diabres.2007.04.012 · DOI
- 10.2337/diacare.24.7.1226 · DOI · Paper page
- 10.1016/S0140-6736(14)61335-0 · DOI · Paper page
- 10.1016/j.pec.2009.09.033 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1016/S0002-9343(01)00742-2 · DOI · Paper page
- 10.2337/diacare.28.2.278 · DOI
- 10.1186/1471-244X-13-260 · DOI · Paper page
- 10.1001/archopht.1989.01070010243030 · DOI · Paper page
- 10.1001/archopht.1989.01070010250031 · DOI · Paper page
- 10.1016/S0140-6736(03)12267-2 · DOI · Paper page
- 10.1111/j.1464-5491.2009.02820.x · DOI
- 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- 10.1001/archopht.122.11.1631 · DOI · Paper page
- 10.1016/S0140-6736(07)61607-9 · DOI · Paper page
- 10.1016/S0161-6420(78)35693-1 · DOI · Paper page
- Evans JR, 2014, Laser photocoagulation for proliferative diabetic retinopathy, Cochrane Database Syst Rev, 11, CD011234
- 10.2337/diacare.18.5.631 · DOI · Paper page
- 10.1007/BF00137653 · doi:10.1007/bf00137653
- 10.2337/diacare.25.5.859 · DOI · Paper page
- 10.1161/01.STR.0000254547.91276.50 · DOI · Paper page
- 10.2337/dc12-1311 · DOI
- 10.1016/j.ophtha.2012.08.029 · DOI
- 10.1007/s00125-010-2025-0 · DOI
- 10.1053/j.ajkd.2008.12.034 · DOI · Paper page
- 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1001/archinternmed.2011.537 · DOI · Paper page
- 10.1136/bmj.317.7160.703 · DOI · Paper page
- 10.1111/j.1463-1326.2012.01566.x · doi:10.1111/j.1463-1326.2012.01566.x
- 10.1016/j.diabres.2004.02.015 · DOI
- 10.1016/S0140-6736(05)67814-2 · DOI · Paper page
- Suckling RJ, 2010, Altered dietary salt intake for preventing and treating diabetic kidney disease, Cochrane Database Syst Rev, CD006763
- 10.2337/diacare.24.1.111 · DOI
- 10.1046/j.1523-1755.2002.00421.x · DOI · Paper page
- 10.1007/s00125-009-1467-8 · DOI
- 10.1159/000190270 · DOI · Paper page
- 10.1681/ASN.2012070718 · DOI · Paper page
- 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
- Hotta N, 1996, Diabetic Neuropathy, 145
- 10.2337/diacare.28.4.956 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1212/WNL.37.4.589 · DOI · Paper page
- 10.2337/dc07-2105 · DOI · Paper page
- 10.1111/j.1464-5491.2010.03152.x · DOI
- 10.1111/j.1526-4637.2007.00305.x · DOI
- 10.1111/j.2040-1124.2010.00073.x · DOI
- 10.2337/dc10-0456 · DOI
- Japanese Study Group on Diabetic Neuropathy, 2012, Simplified diagnostic criteria and clinical staging of diabetic polyneuropathy, Peripheral Nerve, 23, 109
- 10.1016/S1067-2516(07)60001-5 · DOI · Paper page
- 10.2337/dc07-1178 · DOI · Paper page
- 10.1016/0002-9610(89)90183-9 · DOI · Paper page
- 10.1136/bmj.321.7258.405 · DOI · Paper page
- Edmonds ME, 1986, Improved survival of the diabetic foot: the role of a specialized foot clinic, Q J Med, 60, 763
- 10.1016/j.jacc.2011.08.023 · DOI · Paper page
- 10.1093/cid/cis346 · DOI · Paper page
- 10.1002/dmrr.2299 · DOI
- 10.1007/s001250051459 · DOI · Paper page
- 10.1016/S1262-3636(07)70193-3 · DOI
- 10.1016/j.jdiacomp.2007.06.006 · DOI
- 10.2337/diacare.27.6.1286 · doi:10.2337/diacare.27.6.1286
- 10.1007/s00125-012-2673-3 · DOI · Paper page
- 10.2337/dc13-1545 · DOI
- 10.1136/bmj.321.7258.405 · DOI · Paper page
- 10.1136/bmj.321.7258.412 · DOI · Paper page
- 10.2165/11638240-000000000-00000 · DOI
- 10.1371/journal.pone.0111247 · DOI
- 10.1007/s11606-011-1757-y · DOI
- 10.1016/S0140-6736(09)60503-1 · DOI · Paper page
- Takahashi K, 2001, Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus, J Int Acad Periodontol, 3, 104
- 10.1177/0022034511431583 · DOI
- 10.1111/jdi.12026 · DOI
- 10.2337/dc08-0026 · DOI · Paper page
- 10.1902/jop.2013.1340013 · DOI · Paper page
- 10.1902/jop.2013.1340017 · DOI
- Matsuzawa Y, 2006, Guidelines for the management of obesity disease 2006, Obesity Research, 12, 1
- Saito Y, 2011, Diagnostic criteria for obesity disease 2011, Obesity Research, 17, 1
- 10.1093/pubmed/fdt061 · DOI
- 10.1007/s11695-013-1160-3 · DOI · Paper page
- 10.2169/naika.94.794 · DOI · Paper page
- 10.2337/dc16-S012 · DOI
- 10.1161/CIRCULATIONAHA.110.016337 · DOI · Paper page
- 10.1111/j.1751-7176.2012.00648.x · DOI
- 10.1001/jama.2010.884 · DOI · Paper page
- 10.1016/S0272-6386(99)70036-3 · DOI · Paper page
- 10.1016/j.diabres.2013.07.009 · DOI
- 10.1161/CIRCULATIONAHA.113.002529 · DOI · Paper page
- 10.1186/1475-2840-11-109 · DOI
- 10.2337/diacare.22.6.889 · DOI · Paper page
- Hartweg J, 2008, Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus, Cochrane Database Syst Rev, CD003205
- 10.1016/j.diabres.2012.10.004 · DOI · Paper page
- 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
- 10.1016/S0140-6736(05)67667-2 · DOI · Paper page
- 10.1093/qjmed/94.8.435 · DOI · Paper page
- 10.2337/diacare.24.10.1739 · DOI · Paper page
- 10.2337/diacare.18.5.631 · DOI · Paper page
- Sanaka M, 2006, The allowance for pregnancy of women with diabeticnephropathy, J Jpn Soc Diabetes Pregn, 6, 127
- 10.1016/S0140-6736(10)60751-9 · DOI · Paper page
- 10.1016/S0002-9378(94)70097-4 · DOI · Paper page
- Hiramatsu Y, 2015, The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society “An abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria”, J Jpn Diabetes Soc, 58, 801
- 2015, ISPAD Clinical Practice Consensus Guidelines for Pediatric and Adolescent Diabetes 2014
- 10.1111/pedi.12182 · DOI
- 10.1111/pedi.12186 · DOI · Paper page
- 10.1111/pedi.12174 · DOI
- 10.1111/pedi.12179 · DOI · Paper page
- Urakami T, 2012, Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan, Pediatr Endocrinol Rev, 1, 51
- 10.1297/cpe.14.65 · DOI
- 10.2337/dc07-1785 · DOI · Paper page
- 10.1111/pedi.12187 · DOI
- 10.1111/pedi.12191 · DOI · Paper page
- 10.2337/diab.43.8.960 · DOI · Paper page
- 10.1111/j.1532-5415.2012.04099.x · DOI · Paper page
- 10.1111/j.1463-1326.2012.01583.x · DOI · Paper page
- 10.1016/S0140-6736(97)12355-8 · DOI · Paper page
- 10.1056/NEJM199804093381506 · DOI · Paper page
- 10.1016/j.diabres.2011.09.012 · DOI
- 10.2337/dc06-9909 · DOI · Paper page
- 10.1056/NEJMra1309483 · DOI · Paper page
- 10.2337/dc13-3023 · DOI · Paper page
- 10.1001/jama.2014.15298 · DOI · Paper page
- 10.2337/dc16-S004 · DOI
- 10.1056/NEJM199912163412507 · DOI · Paper page
- 10.1136/thoraxjnl-2012-203109 · DOI
- Moberley SA, 2013, Vaccines for preventing pneumococcal infection in adults, Cochrane Database Syst Rev, CD000422
- 10.1111/pedi.12193 · DOI
- 10.1007/s00125-012-2712-0 · DOI
- Sasai H, 2008, [Development of a diabetes risk prediction sheet for specific health guidance], Nihon Koshu Eisei Zasshi, 55, 287
- 10.1111/j.1464-5491.2011.03376.x · DOI
- 10.1093/aje/kws172 · DOI · Paper page
- 10.1097/EDE.0b013e31829f6c31 · DOI
- 10.1111/obr.12129 · DOI
200 of 232 shown
Cited by
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874
“, pancreatitis), and drug- or chemical-induced diabetes (such as after organ transplantation or in the treatment of human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS)) [1,19].”
BackgroundIto, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06870520 · Cited by 234
Yamada, Y., Katagiri, H., Hamamoto, Y., Deenadayalan, S., Navarria, A., Nishijima, K., Seino, Y., Fukushima, Y., Hamamoto, Y., Hisatomi, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30075-9 · Cited by 228
Yabe, D., Nakamura, J., Kaneto, H., Deenadayalan, S., Navarria, A., Gislum, M., Inagaki, N., Arisaka, T., Asakura, T., Azuma, N., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30074-7 · Cited by 210
Self-citationGouda, M., Matsukawa, M., & Iijima, H. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s176749 · Cited by 46
Metadata
- Authors
- Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E.
- Venue
- Journal of Diabetes Investigation
- Publisher
- Wiley
- Published
- 2018-03-26
- Volume
- 9
- Issue
- 3
- Pages
- 657-697
- ISSN
- 2040-1116 (ISSN-L)
- 2040-1124
- OpenAlex
- W4211190017
- Cited by
- 181
- References
- 84
- FWCI
- 24.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-18)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Japanese Clinical Practice Guideline for Diabetes 2016. https://app.cochat.ai/papers/10.1111/jdi.12810
- The paper
- Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018). Japanese Clinical Practice Guideline for Diabetes 2016. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.12810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.